Arena's diet drug castoff deemed safe in study; UK price overseers say breakthrough CAR-T Yescarta is too expensive
→ Arena Pharmaceuticals never could make much money from their weight loss drug Belviq (lorcaserin). But at least researchers have good reason to believe it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
